Gabriel Ocana Santero
FounderFounder at Exin Therapeutics
South San Francisco, California, United States
FoundedExin Therapeutics · YC
About
Gabriel Ocana Santero holds an MSc in Neuroscience and PhD in Pharmacology from Oxford University, with research experience spanning gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. He has conducted work on neurodevelopment and serotonin signaling at the Gatsby Unit at UCL, and now develops gene therapies for neurological conditions at Exin Therapeutics.
Founder at Exin TherapeuticsYC W25
Intro paths
Gabriel went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Jared Friedman, YC Group Partner — the partner who ran Exin Therapeutics's batch and knows the company first-hand. YC profile ↗
In turn, Gabriel can intro founders to Exin Therapeutics's investors below.
Exin Therapeutics's investors · 2
Co-founders at Exin Therapeutics
Experience
- Exin TherapeuticsCEO and Co-foundercurrent2025 — presentSan Francisco Bay Area
- Serotonin and BEYONDSerotonin and Beyond Early Stage Researcher2021 — 2024Oxford, England, United Kingdom
- Gatsby Computational Neuroscience UnitNeuroAI Research Internship2023Greater London, England, United Kingdom
- Fundación "la Caixa"Postgraduate Studies' Fellowship Holder2020 — 2021Oxford, England, United Kingdom
- Centro de Biología Molecular Severo Ochoa, CBMSOResearch Intern2020Greater Madrid Metropolitan Area
- Karolinska InstitutetResearch Intern2019Greater Stockholm Metropolitan Area
- Medical University of ViennaResearch Intern2018Austria
Skills & more
Languages English · French · Spanish
- The Science and Business of Biotechnology — MITx Courses
- TOEFL-ibt (113/120) — TOEFL
From Gabriel's professional profile.
Frequently asked questions
- Who is Gabriel Ocana Santero?
- Gabriel Ocana Santero holds an MSc in Neuroscience and PhD in Pharmacology from Oxford University, with research experience spanning gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. He has conducted work on neurodevelopment and serotonin signaling at the Gatsby Unit at UCL, and now develops gene therapies for neurological conditions at Exin Therapeutics.
- Where does Gabriel Ocana Santero work?
- Gabriel Ocana Santero is Founder of Exin Therapeutics.
- What companies did Gabriel Ocana Santero found?
- Gabriel Ocana Santero founded Exin Therapeutics.
- Where did Gabriel Ocana Santero go to school?
- Gabriel Ocana Santero studied at University of Oxford (Doctor of Philosophy - PhD, Pharmacology); Y Combinator (W25, Biotechnology); University of Oxford (Master of Science - MS, Neuroscience).
Founder mafias
Y Combinator mafia9,496
Also came through, then founded or led a company.
+ 9,489 more
Y Combinator mafia5,145
Also came through, then founded or led a company.
+ 5,138 more
University of Oxford mafia424
Also came through, then founded or led a company.
+ 417 more
Boston University mafia102
Also came through, then founded or led a company.
+ 95 more
Universidad Autónoma de Madrid mafia14
Also came through, then founded or led a company.
+ 7 more
Same school
Also attended University of Oxford1,331
+ 1,325 more
Also attended Y Combinator2,000
+ 1,994 more
Also attended Boston University337
+ 331 more
Also attended Universidad Autónoma de Madrid77
+ 71 more
Shared employers
Also worked at Exin Therapeutics1
Also worked at Fundación "la Caixa"3
Also worked at Centro de Biología Molecular Severo Ochoa, CBMSO3
Also worked at Karolinska Institutet23
+ 17 more













































